At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HSCS HeartSciences Inc
Not Yet Opened 12-20 16:00:00 EST
3.83
+0.41
+11.99%
盘后3.52
-0.31-8.09%
19:53 EST
High4.24
Low3.17
Vol149.06K
Open3.53
D1 Closing3.42
Amplitude31.29%
Mkt Cap3.75M
Tradable Cap3.31M
Total Shares980.32K
T/O540.95K
T/O Rate17.24%
Tradable Shares864.74K
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
HeartSciences Price Target Maintained With a $12.00/Share by Maxim Group
SEALCOIN Secures $50 Million Investment Commitment from GEM Digital Limited Through a Structured Token Subscription Agreement of the SEALCOIN Utility Token to Develop Decentralized Physical Internet Network (DePIN)
Heart Test Laboratories, Inc., doing business as HeartSciences, is a medical technology company focuses on applying AI-based technology to an ECG to expand and improve an ECG's clinical utility. It is developing AI-ECG solutions to be made available on a hardware agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is designed to provide diagnostic information related to cardiac dysfunction. The MyoVista also provides conventional ECG information in the same test. The company was incorporated in 2007 and is headquartered in Southlake, Texas.